本文選題：microRNA-195 + 宮頸癌��； 參考：《安徽醫(yī)科大學》2016年博士論文

【摘要】：目的:宮頸癌被認為是婦科最常見的惡性腫瘤之一,同時嚴重危害婦女的身體健康。研究表明微小RNA(micro RNA,miRNA)與宮頸癌的發(fā)生發(fā)展有著密切的聯(lián)系。本文通過研究宮頸癌組織中miRNA-195(miR-195)的表達特點,以明確作用機制。方法:利用qRT-PCR方法分別檢測人宮頸癌組織與正常組織的miR-195的表達并進行比較。培養(yǎng)宮頸癌細胞,并轉(zhuǎn)染miR-195以及其抑制物,采用MTT法、transwell小室法觀察miR-195對宮頸癌細胞在細胞增殖、細胞遷移以及細胞侵襲方面的作用。篩選miR-195可能的靶基因并采用western blot法觀察其表達及與miR-195的關(guān)系。結(jié)果:miR-195的表達在宮頸癌組織、細胞中均顯著地下調(diào)。過表達miR-195能顯著抑制細胞的生長。而抑制了miR-195則對細胞增殖具有相反的作用。miR-195的異常表達顯著地抑制了He La和C33A細胞的遷移。而阻斷miR-195的表達能增強He La和C33A細胞的遷移。過表達miR-195減輕了He La和C33A細胞的侵襲,而阻斷miR-195的表達能增強He La和C33A細胞的侵襲。根據(jù)生物信息學分析預(yù)測,HDGF是miR-195的直接靶基因。根據(jù)western blot結(jié)果,在宮頸癌細胞中,HDGF顯著上調(diào)。在He La和C33A細胞轉(zhuǎn)染了miR-195 mimics以后,HDGF在m RNA水平不受影響;相反的,轉(zhuǎn)染了miR-195 mimics以后,HDGF在蛋白水平下調(diào),而轉(zhuǎn)染了miR-195 inhibitor以后,HDGF在蛋白水平顯著上調(diào)。結(jié)論:miR-195在細胞試驗中抑制了宮頸癌細胞的增殖,遷移以及侵襲。確定了HDGF是miR-195的m RNA直接靶點。miR-195通過靶向調(diào)控HDGF進而發(fā)揮抑制宮頸癌細胞增殖,遷移以及侵襲行為。
[Abstract]:Objective: cervical cancer is considered to be one of the most common malignant tumors in gynecology. Studies have shown that RNA(micro miRNAs are closely related to the occurrence and development of cervical cancer. The expression of miRNA-195 miR-195 in cervical carcinoma was studied to clarify the mechanism. Methods: qRT-PCR method was used to detect the expression of miR-195 in human cervical carcinoma and normal tissues. Cervical cancer cells were cultured and transfected with miR-195 and their inhibitors. The effects of miR-195 on cell proliferation, cell migration and cell invasion were observed by MTT transwell chamber assay. The possible target genes of miR-195 were screened and their expression and relationship with miR-195 were observed by western blot assay. Results the expression of miR-195 was significantly down-regulated in cervical cancer cells. Overexpression of miR-195 significantly inhibited cell growth. On the contrary, inhibition of miR-195 on cell proliferation. The abnormal expression of miR-195 significantly inhibited the migration of He-La and C33A cells. Blocking the expression of miR-195 enhanced the migration of He-La and C33A cells. Overexpression of miR-195 alleviated the invasion of He-La and C33A cells, while blocking the expression of miR-195 enhanced the invasion of He-La and C33A cells. According to bioinformatics analysis, it is predicted that HDGF is a direct target gene of miR-195. According to western blot results, HDGF was significantly up-regulated in cervical cancer cells. After transfection of He-La and C33A cells into miR-195 mimics, the level of m RNA was not affected. On the contrary, after transfection of miR-195 mimics, the protein level of He-La and C33A cells was down-regulated, but after transfection of miR-195 inhibitor, the level of miR-195 mimics was significantly up-regulated. Conclusion the cell proliferation, migration and invasion of cervical cancer cells were inhibited by the cell test. It is confirmed that HDGF is the direct target of m RNA of miR-195. MiR-195 inhibits the proliferation, migration and invasion of cervical cancer cells by targeting HDGF.
【學位授予單位】：安徽醫(yī)科大學
【學位級別】：博士
【學位授予年份】：2016
【分類號】：R737.33

【相似文獻】

相關(guān)期刊論文 前10條

1 趙紅曄;杜樾;;宮頸癌297例臨床病理分析[J];中國社區(qū)醫(yī)師(醫(yī)學專業(yè)半月刊);2008年15期

2 徐艷紅;;宮頸癌的致病因素及預(yù)防的研究綜述[J];中國實用醫(yī)藥;2009年25期

3 畢建軍;楊慧蘭;;單純皰疹病毒2型與宮頸癌相關(guān)性的研究進展[J];實用醫(yī)學雜志;2011年03期

4 孟斐;;組織因子途徑抑制物-2在宮頸癌中表達情況的研究分析[J];中國實用醫(yī)藥;2013年05期

5 劉威;高文霞;;宮頸癌患者組織及血清血管內(nèi)皮生長因子的變化研究[J];中國藥物經(jīng)濟學;2013年04期

6 拉萊·蘇祖克;表皮生長因子受體和轉(zhuǎn)化生長因子-α在宮頸癌中的表達[J];診斷病理學雜志;2000年04期

7 許爭峰,胡婭莉,王迅美,戴魯琴,韓克,束澤寶;宮頸組織標本中端粒酶活性檢測及臨床意義[J];江蘇醫(yī)藥;2001年05期

8 鄒紅燕,姚安梅,楊栓雀,趙西俠;青年宮頸癌相關(guān)因素分析[J];陜西腫瘤醫(yī)學;2001年03期

9 張忠福,李輝;宮頸癌合并妊娠的診斷與治療[J];中國實用婦科與產(chǎn)科雜志;2004年07期

10 小松;;宮頸癌已成女性殺手[J];中國醫(yī)藥指南;2004年03期

相關(guān)會議論文 前10條

1 譚文福;吳緒峰;陳惠禎;;年輕宮頸癌的臨床特征及防治[A];全國子宮頸癌暨湖北省婦科腫瘤專業(yè)委員會第五次婦科腫瘤學術(shù)會議論文匯編[C];2006年

2 王勒渝;;宮頸Ⅰ號栓阻斷宮頸癌發(fā)生的組織病理學、超微結(jié)構(gòu)及免疫組織化學的研究[A];第八屆全國中西醫(yī)結(jié)合腫瘤學術(shù)會議論文集[C];2000年

3 段微;;超高頻無線電波刀治療宮頸癌前病變的研究[A];2000全國腫瘤學術(shù)大會論文集[C];2000年

4 黃妙玲;陳R，

本文編號：1892569